Unlock stock picks and a broker-level newsfeed that powers Wall Street.
2.1000
+0.0300
+(1.45%)
At close: 4:00:02 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | -0.53 | -0.64 | -2.37 | -1.14 |
Low Estimate | -0.53 | -0.64 | -2.54 | -1.33 |
High Estimate | -0.53 | -0.64 | -2.19 | -0.96 |
Year Ago EPS | -0.65 | -0.61 | -2.4 | -2.37 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | 1M | -- |
Sales Growth (year/est) | 0.00% | 0.00% | -100.00% | 0.00% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.73 | -0.75 | -0.75 | -0.76 |
EPS Actual | -0.65 | -0.61 | -0.59 | -0.55 |
Difference | 0.07 | 0.14 | 0.16 | 0.21 |
Surprise % | 10.34% | 18.67% | 21.33% | 27.63% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.53 | -0.64 | -2.37 | -1.14 |
7 Days Ago | -0.74 | -0.61 | -2.54 | -1.14 |
30 Days Ago | -0.74 | -0.61 | -2.54 | -1.14 |
60 Days Ago | -0.74 | -0.61 | -2.29 | -1.14 |
90 Days Ago | -0.74 | -0.61 | -2.36 | -1.33 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
LSTA | 18.46% | -4.92% | 1.46% | 51.59% |
S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/11/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/21/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 9/18/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/13/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 7/19/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 7/10/2024 |
Related Tickers
SEER Seer, Inc.
1.6600
-1.78%
PMVP PMV Pharmaceuticals, Inc.
0.9950
-0.50%
ANTX AN2 Therapeutics, Inc.
1.4000
0.00%
OMGAQ
0.0330
-64.86%
GRTX Galera Therapeutics, Inc.
0.0275
-0.36%
THRD Third Harmonic Bio, Inc.
3.5700
+0.56%
TBPH Theravance Biopharma, Inc.
8.77
-2.66%
5KW.F SkinBioTherapeutics plc
0.2800
-0.71%
ZVA.SG Cellectis SA
1.1720
-2.33%
HQ1.MU Oruka Therapeutics Inc. R
8.80
-2.76%